Work

Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning

Year: 2002

Type: review

Source: Nature reviews. Neuroscience

DOI: 10.1038/nrn938

Author: Dale Schenk

Institution: Elan Pharmaceuticals, Inc. (Ireland)

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2050181337

FWCI: 3.732

Cites: 22

Cited by: 436

Related to: 10